362 related articles for article (PubMed ID: 9375961)
21. Autoradiographic localization of the [3H]-(S)-zacopride labelled 5-HT3 receptor in porcine brain.
Fletcher S; Barnes NM
Neurosci Lett; 1999 Jul; 269(2):91-4. PubMed ID: 10430512
[TBL] [Abstract][Full Text] [Related]
22. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
23. Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells.
Lummis SC; Martin IL
Mol Pharmacol; 1992 Jan; 41(1):18-23. PubMed ID: 1370706
[TBL] [Abstract][Full Text] [Related]
24. Molecular properties of 5-hydroxytryptamine3 receptor-type binding sites purified from NG108-15 cells.
Boess FG; Lummis SC; Martin IL
J Neurochem; 1992 Nov; 59(5):1692-701. PubMed ID: 1402914
[TBL] [Abstract][Full Text] [Related]
25. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
[TBL] [Abstract][Full Text] [Related]
26. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
Steward LJ; West KE; Kilpatrick GJ; Barnes NM
Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
[TBL] [Abstract][Full Text] [Related]
27. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptors.
Gehlert DR; Schober DA; Gackenheimer SL; Mais DE; Ladouceur G; Robertson DW
Neurochem Int; 1993 Oct; 23(4):373-83. PubMed ID: 8220179
[TBL] [Abstract][Full Text] [Related]
29. Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors.
Akuzawa S; Miyake A; Miyata K; Fukutomi H
Eur J Pharmacol; 1996 Jan; 296(2):227-30. PubMed ID: 8838461
[TBL] [Abstract][Full Text] [Related]
30. Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes.
McKernan RM; Quirk K; Jackson RG; Ragan CI
J Neurochem; 1990 Mar; 54(3):924-30. PubMed ID: 2303819
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue.
Barnes JM; Barnes NM; Costall B; Ironside JW; Naylor RJ
J Neurochem; 1989 Dec; 53(6):1787-93. PubMed ID: 2809591
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers.
Pinkus LM; Sarbin NS; Gordon JC; Munson HR
Eur J Pharmacol; 1990 Apr; 179(1-2):231-5. PubMed ID: 2364986
[TBL] [Abstract][Full Text] [Related]
33. Differential distribution of 5-hydroxytryptamine3 receptor in the colon between human and guinea pig.
Sakurai-Yamashita Y; Yamashita K; Kaibara M; Enjoji A; Kanematsu T; Taniyama K
Chin J Physiol; 1999 Sep; 42(3):195-8. PubMed ID: 10707894
[TBL] [Abstract][Full Text] [Related]
34. Purification to homogeneity of an active opioid receptor from rat brain by affinity chromatography.
Loukas S; Mercouris M; Panetsos F; Zioudrou C
Proc Natl Acad Sci U S A; 1994 May; 91(10):4574-8. PubMed ID: 8183950
[TBL] [Abstract][Full Text] [Related]
35. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a mouse serotonin 5-HT3 receptor purified from mammalian cells.
Hovius R; Tairi AP; Blasey H; Bernard A; Lundström K; Vogel H
J Neurochem; 1998 Feb; 70(2):824-34. PubMed ID: 9453579
[TBL] [Abstract][Full Text] [Related]
37. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
38. Solubilization and characterization of high-affinity [3H]serotonin binding sites from bovine cortical membranes.
VandenBerg SR; Allgren RL; Todd RD; Ciaranello RD
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3508-12. PubMed ID: 6574495
[TBL] [Abstract][Full Text] [Related]
39. [125I]S(-)-zacopride labels a novel 5-hydroxytryptamine sensitive recognition site in rat duodenum and ileum.
Ge J; Towers P; Patel AC; Barnes NM
Eur J Pharmacol; 1996 Apr; 300(1-2):113-7. PubMed ID: 8741175
[TBL] [Abstract][Full Text] [Related]
40. Molecular size of the 5-HT3 receptor solubilized from NCB 20 cells.
McKernan RM; Biggs CS; Gillard N; Quirk K; Ragan CI
Biochem J; 1990 Aug; 269(3):623-8. PubMed ID: 2390056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
